Korea Arlico Pharm Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May '26 May 28, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	43,835	65,523	52,955	87,364	100,392	117,712
Market Cap Growth	-32.78%	23.73%	-39.39%	-12.98%	-14.71%	-17.59%
Enterprise Value	67,597	98,063	83,746	102,863	93,513	100,409
Last Close Price	2860.00	4275.00	3397.16	5483.79	6160.30	7081.66
PE Ratio	-	-	-	28.54	12.50	23.88
PS Ratio	0.22	0.33	0.28	0.47	0.60	0.84
PB Ratio	0.57	0.84	0.67	0.98	1.13	1.45
P/TBV Ratio	0.65	0.94	0.73	1.07	1.23	1.53
P/FCF Ratio	3.58	9.52	-	-	-	31.82
P/OCF Ratio	2.98	6.56	-	12.22	20.76	13.13
EV/Sales Ratio	0.34	0.49	0.44	0.55	0.56	0.72
EV/EBITDA Ratio	25.10	16.56	57.52	13.11	7.21	13.57
EV/EBIT Ratio	-	99.13	-	33.48	9.48	20.94
EV/FCF Ratio	5.52	14.25	-	-	-	27.14
Debt / Equity Ratio	0.59	0.63	0.63	0.52	0.35	0.16
Debt / EBITDA Ratio	16.64	8.28	34.65	5.90	2.40	1.70
Debt / FCF Ratio	3.66	7.13	-	-	-	3.41
Net Debt / Equity Ratio	0.31	0.36	0.39	0.17	-0.01	-0.20
Net Debt / EBITDA Ratio	8.82	4.74	21.47	1.98	-0.08	-2.18
Net Debt / FCF Ratio	1.94	4.08	-2.59	-0.95	0.08	-4.36
Asset Turnover	1.16	1.17	1.10	1.15	1.22	1.21
Inventory Turnover	2.76	2.96	3.05	2.84	2.58	2.72
Quick Ratio	0.63	0.66	0.66	0.76	0.91	1.43
Current Ratio	1.09	1.12	1.14	1.19	1.43	2.04
Return on Equity (ROE)	-2.09%	-0.77%	-6.35%	3.45%	9.47%	6.21%
Return on Assets (ROA)	-0.65%	0.36%	-1.86%	1.17%	4.49%	2.59%
Return on Invested Capital (ROIC)	-1.73%	0.91%	-4.79%	2.82%	12.39%	6.35%
Return on Capital Employed (ROCE)	-1.90%	1.00%	-5.30%	3.00%	10.20%	5.50%
Earnings Yield	-3.71%	-0.92%	-10.12%	3.50%	8.00%	4.19%
FCF Yield	27.93%	10.51%	-22.82%	-18.58%	-14.08%	3.14%
Payout Ratio	-	-	-	63.76%	13.08%	19.43%
Buyback Yield / Dilution	-0.99%	-0.03%	49.01%	-94.89%	-0.18%	0.06%